Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-27

Clinical Trial Update: Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland [NA]

View source ↗

Summary

Clinical trial update on HbA1c after initiating a continuous glucose monitoring (CGM) system in adults with type 2 diabetes treated with basal insulin in Finlan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Continuous glucose monitor (CGM) device

Snippet

Sponsor: Abbott Diabetes Care | Conditions: Type 2 Diabetes Treated With Insulin | NA | Status: TERMINATED